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E
very day, a healthy human loses billions of cells by 
design [1]. Cell death processes, such as apoptosis 
and other tightly regulated mechanisms that kill old, 
damaged, or unwanted cells, are critically important for 
normal embryonic development and for the maintenance of 
physiological functions in multicellular organisms (and likely 
in unicellular species as well) [1,2]. Insufficient or excessive 
cell death underlies most human pathologies, including 
cancer, autoimmunity, infectious diseases, and degenerative 
disorders. Thus, it is not surprising that efforts at identifying 
the factors responsible for cell death and elucidating their 
detailed mechanisms of action have received considerable 
research attention.
Much of this attention has focused on the Bcl-2 protein 
family, which has been recognized as the principal regulatory 
component of the intracellular apoptotic machinery for 
over two decades [3]. Bcl-2 family proteins can either inhibit 
or promote apoptosis, largely depending on the number 
of Bcl-2 homology (BH) domains they share. For example, 
anti-apoptotic family members, such as Bcl-2 and Bcl-XL, 
have four BH domains, while pro-apoptotic members such as 
Bax and Bak contain three, and a third subset, the BH3-only 
proteins, contains just one. Although there is growing interest 
in the newly identified roles that both pro- and anti-death 
Bcl-2 family proteins play in healthy cells—for example, in 
membrane fission and fusion mechanisms, mitochondrial 
autophagy, neuronal activity, and cellular energetics [3,4]—
most current research is focused on the functions of this 
family during cell death. Though not universally accepted, 
it is widely thought that Bcl-2 family proteins regulate 
commitment to apoptosis primarily through their capacity 
to control the permeability of the outer mitochondrial 
membrane (OMM): permeabilization triggers the release of 
multiple apoptogenic factors into the cytosol and/or leads to 
mitochondrial dysfunction [5]. Various Bcl-2 family members 
affect this key event of the apoptotic cascade in different ways, 
determining their pro- or anti-apoptotic status. The Bcl-2-type 
proteins inhibit OMM permeabilization, thereby preserving 
cell viability. In contrast, Bax-type proteins and the diverse 
group of BH3-only proteins facilitate OMM permeabilization 
and thus promote cell death. Yet despite intense effort, the 
question of exactly how different types of Bcl-2 family proteins 
fulfil these tasks remains actively debated [3,5,6]. 
The Bcl-2 Network
Part of the difficulty in resolving the functions of Bcl-2 family 
proteins is the inherent complexity of the cellular apoptotic 
network. An additional hurdle is that Bcl-2 protein action 
likely occurs at membranes, and membrane proteins can be 
made to reveal their secrets only with difficulty, as lipid-based 
systems are more challenging to study. Fortunately, basic 
aspects of the regulation of OMM permeability by Bcl-2 family 
proteins appear amenable to reconstitution in vitro, using 
simplified systems made up of purified proteins and lipids. As 
a prominent example, early studies from several laboratories 
using recombinant proteins and pure lipid membranes 
revealed that pro-apoptotic (activated) Bax has an intrinsic 
pore-forming activity [7–9]. These and other results obtained 
from reconstitution approaches were critical to establishing 
the currently popular view that the primary pro-death 
function of Bax-type proteins is direct permeabilization of 
the OMM. However, understanding exactly how Bcl-2-type 
proteins and BH3-only proteins regulate Bax permeabilizing 
function has proven more difficult. 
Bax is often found as a monomeric protein in the cytosol 
of healthy cells. In cells committed to death, Bax appears to 
change conformation, translocate to the OMM, and assemble 
into intramembrane complexes [3]. BH3-only proteins funnel 
diverse apoptotic signals so as to trigger Bax conformational 
change and Bax-driven OMM permeabilization, but many 
details of this molecular pathway remain unclear. On the 
other hand, although essentially all Bcl-2 family proteins 
have been reported to bind a wide range of diverse protein 
partners, it has long been recognized that the ability of 
different Bcl-2 family members to engage in selective protein–
protein interactions with other family members is integral 
to their anti- and pro-death functions [1]. Indeed, structural 
studies sustain the notion that an elongated hydrophobic 
groove on pro-survival proteins can act as a “receptor” 
binding-pocket for the amphipathic (that is, hydrophobic at 
one side and hydrophilic at the other) α-helical BH3 “ligand” 
of pro-apoptotic partners [10]. 
Largely based on these notions, two major competing 
models have been proposed (Figure 1). On the one hand, the 
“sensor-only BH3” or “displacement” model (also known as 
the “indirect” model for BH3-only proteins, and the “direct” 
model for Bcl-2 types) postulates that Bcl-2-type proteins 
directly bind to and neutralize Bax-type proteins. In turn, 
Bax-type proteins auto-activate when their anti-apoptotic 
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Bcl-2 partner is displaced upon binding to a BH3-only protein 
[11]. One complication with this model is that mutants of 
Bcl-2-type proteins that fail to bind Bax and Bak can be fully 
protective against cell death. The alternative “split BH3” 
model (“direct” model for BH3-only, “indirect” model for 
Bcl-2 types) posits that Bax-type proteins are activated via 
interactions with a selective subset of activator-type BH3-only 
members, such as cleaved/truncated Bid (tBid), and that 
Bcl-2-type proteins act by sequestering these activator-type 
BH3-only proteins, rather than Bax-type proteins [12,13]. As 
in the sensor-only model, the sensor-type BH3-only proteins 
such as Bad can still inactivate Bcl-2-type proteins. A major 
complication with this model is that direct interactions 
between activator-type BH3-only proteins and Bax-type 
proteins are difficult to detect. There are other permutations 
of these two models, such as the “hierarchical model,” in 
which unrelated cell factors engage Bcl-2 family proteins 
to act at intermediate steps, alleviating the need for direct 
binding of BH3-only and Bax-type proteins [3,5,6]. One 
potential downside of all of these models is that many of the 
protein–protein interaction specificities were determined 
from solution-based studies in the absence of (or following 
extraction from) membranes, or with protein fragments 
instead of full-length proteins. Presumably the behavior of 
soluble Bcl-2 proteins and derived peptides will not fully 
reveal their mechanisms of action at the mitochondrial (or 
other) membrane locus. 
Dual Interaction Model
In this issue of PLoS Biology, Billen et al. elegantly address this 
problem using a powerful combination of approaches applied 
to in vitro reconstitution systems appropriately consisting of 
full-length purified proteins and relevant membrane targets 
(isolated mitochondria and pure lipid OMM-like vesicles, or 
liposomes) [14]. One important contribution of the study is 
the demonstration that Bcl-XL engages in stable interactions 
with both Bax and tBid, rather than with only one of the two 
pro-apoptotic molecules, as had been proposed in previous 
models [11–13]. Moreover, substantial correlation between 
mitochondria- and liposome-based systems was found, 
whereby Bcl-XL forms two different stable heterodimers, one 
with Bax, the other with tBid, and both of these interactions 
contribute to the neutralization of the Bax permeabilizing 
function. An exciting avenue for further research will be 
the development of assays in reconstituted systems that 
allow detection and monitoring of dynamic (rather than 
static) interactions between specific anti- and pro-apoptotic 
Bcl-2 family members plus additional cellular proteins in 
membranes.
Billen et al. [14] also provide important mechanistic 
insight by delineating three distinct actions of Bcl-XL that 
inhibit activation of Bax permeabilizing function. Toward 
this end, the investigators focused on studies using OMM-
like liposomes. First, they show that Bcl-XL abrogates the 
transient association of Bax with the liposome surface 
that is necessary for shifting soluble Bax molecules into a 
conformation that is susceptible to productive interactions 
with tBid [15]. In addition, Bcl-XL directly competes with 
soluble Bax for binding to tBid, thereby preventing the tBid–
Bax interactions that are required for effective recruitment 
of Bax to the liposome bilayer and for subsequent events 
leading to intramembranous Bax oligomerization. Finally, 
Bcl-XL also neutralizes homotypic Bax interactions that 
contribute to activation of the Bax permeabilizing function. 
Oligomerization perhaps involves the BH3 motif of one 
Bax molecule binding in the BH3 binding pocket on the 
opposite face of the next Bax molecule, as recently proposed 
for Bak [16]. Thus, in contrast to the previous linear models, 
this report provides the strongest evidence to date that Bcl-
XL uses multiple mechanisms to neutralize functional Bax 
activation. 
Another intriguing outcome of this study is the observation 
that interaction of tBid and/or activated Bax with Bcl-
XL triggers translocation of Bcl-XL to the membrane. 
Structural studies with the Bcl-XL homologue Bcl-w [10] 
revealed that, like Bax, a C-terminal hydrophobic helix folds 
intramolecularly, occupying the same hydrophobic groove 
previously assumed to act only as the BH3-binding pocket. 
Once freed from the rest of the protein, the C-terminal 
hydrophobic helix functions as a transmembrane domain 
through which Bcl-2 family proteins can be anchored to the 
OMM. Therefore, one explanation is that engagement of the 
BH3 domain of tBid and/or activated Bax into the Bcl-XL 
hydrophobic groove displaces the C-terminal hydrophobic 
helix of Bcl-XL, allowing anchoring of the protein to the 
lipid bilayer. 
Future Directions
Notwithstanding these important contributions, the model 
presented in this study also raises fascinating new questions. 
Chief among these: what is the structure adopted by Bcl-XL 
in the membrane, and how does this structure explain the 
inhibition of Bax permeabilizing function? One possibility is 
doi:10.1371/journal.pbio.0060154.g001
Figure 1. Schematic Models to Explain the Functional Relationships 
between Bcl-2 Family Proteins 
Depicted are the anti-death Bcl-2-type protein Bcl-XL, the pro-death 
protein Bax, and the BH3-only proteins Bid (N-terminally truncated Bid 
or tBid, an activator- or sensor-type), and Bad (sensor-type BH3-only 
protein). (A) In the sensor-only model, all BH3-only proteins serve to 
inactivate Bcl-2-like cell death inhibitors, which when released allow 
activation and oligomerization of Bax. (B) In the split BH3 model, 
some BH3-only proteins act upstream of Bcl-2-types, while others act 
downstream. The BH3-only protein tBid is sequestered by Bcl-XL, and 
when tBid is displaced by sensor-type BH3-only protein Bad, tBid is freed 
to activate Bax, which in turn oligomerizes in the membrane to facilitate 
release of pro-apoptotic proteins. (C) In the dual interaction model put 
forth by Billen and colleagues, Bcl-XL can interact with either Bax or tBid 
in the same sample.PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 1150 June 2008  |  Volume 6  |  Issue 6  |  e154
that membrane-associated Bcl-XL adopts an overall structure 
similar to that found in solution, except with its C-terminal 
helix inserted into the lipid bilayer in a transmembrane 
orientation (Figure 2A and 2B). This would allow interactions 
of the Bcl-XL groove with BH3 domains from pro-apoptotic 
partners sequestering Bax and/or tBid at the membrane 
locus, either of which could result in neutralization of Bax-
mediated membrane permeabilization. 
Alternative possibilities exist. Indeed, biochemical labeling 
of Bcl-2 and Bax in cells previously led to the conclusion 
that both proteins insert a central helical hairpin into 
the lipid bilayer of the OMM [17,18]. This conclusion is 
consistent with structural similarities found between Bcl-2- 
and Bax-type proteins and bacterial pore-forming toxins 
such as colicins and diphtheria toxin [10,19]. Moreover, 
this conformation was linked to the anti-apoptotic function 
of Bcl-2 due to neutralizing hairpin–hairpin interactions 
with Bax [20]. In line with this observation, biophysical 
studies with model membranes suggest that not only Bcl-2 
but also Bcl-XL can insert central helical hairpins into the 
hydrophobic matrix of the lipid bilayer [21,22]. However, 
much remains to be learned concerning the orientation and 
depth of penetration within the lipid bilayer of helical hairpin 
segments of different Bcl-2 family members (Figure 2C and 
2D). Regardless, it is important to point out that membrane 
insertion of the central helical hairpin almost certainly 
eliminates the BH3-binding pocket present in soluble 
structures of Bcl-2-type proteins. Additional controversies 
arise from studies relating membrane conformational 
changes of Bcl-2-type proteins with acquisition of a pro-
apoptotic phenotype due to BH3 domain exposure [23,24] 
and/or to unleashing of a latent Bax-like pore-forming 
activity [25–27]. Yet a rigorous structural understanding of 
the conformational transitions in either Bax-type- or Bcl-2-
type proteins responsible for exposure of the normally buried 
BH3 domain or for membrane permeabilization is currently 
lacking. Clearly, these observations beg further exploration 
of the structural properties of Bcl-2 family proteins in 
membrane environments. 
Another exciting avenue for future research relates to the 
possible implication of OMM lipids in the function of Bcl-2 
family proteins. Indeed, results obtained in model systems 
examining the lipid-dependence of Bax permeabilizing 
function lend support to a model whereby Bax permeabilizes 
the OMM by forming proteolipidic pores [9,28,29], akin 
to the mechanism of action proposed for colicins and 
other pore-forming toxins/peptides [30]. More recently, 
the levels of cardiolipin (and its degradation/oxidation 
derivatives) [31,32] and cholesterol [33,34] at the OMM level 
were implicated in regulating different stages of the Bax-
driven membrane permeabilization pathway. Furthermore, 
functional coupling of tBid (but not Bim) with Bax in 
reconstituted systems involves specific tBid–cardiolipin 
interactions [35]. Based on these observations, it is reasonable 
to speculate that OMM lipids also play a role in the biological 
function of Bcl-2-type proteins. For example, Bcl-2-type 
proteins may interact with cardiolipin, cholesterol, or other 
OMM lipids that accumulate at the OMM during apoptosis 
[36] to control the Bax-driven membrane permeabilization 
pathway. Alternatively or in addition, the conformation and 
biological function of Bcl-2-type proteins themselves may 
be modulated via specific interactions with particular OMM 
lipids and/or through composition-dependent physical 
properties of the OMM bilayer. Simple model systems will 
provide a powerful tool with which to test the validity of these 
and other hypotheses on the mechanism of Bcl-2 protein 
action.  
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